The development of Remternetug could have a significant impact on individuals and families affected by Alzheimer's disease. If successful, the drug may slow disease progression, allowing patients to maintain their independence for a longer period. However, the drug is still in the research phase, and its effectiveness and safety must be confirmed through clinical trials. The outcome of these trials will determine whether the drug can be approved by the FDA and made available to the public.